HEALTHCARE | RENAL | DIALYSIS Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.7 million patients worldwide regularly undergo dialysis treatment. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. STRATEGY - FRESENIUS MEDICAL CARE Our way forward – Strategy 2025. Creating a future worth living. For patients. Worldwide. Every day. This is our vision that unites all of us at Fresenius Medical Care – it always has and always will. We believe that in the future, health care will not be as we know it today. It faces multiple challenges: An ageing population and a rise

in

POLICIES AND STANDARDS Sustainability Accounting Standards Board (SASB) Index. Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

EMPLOYEES - FRESENIUS MEDICAL CARE We will continue to promote diversity in the future, emphasizing and embracing it as an asset. The average age of employees in 2019 was 41 years. Around 18 % of employees were below 30, the majority of. 56 % were between 30 and 50 years old and 26 % of employees were 50

6008 CARESYSTEM

With the 6008 CAREsystem*, Fresenius Medical Care leverages leading-edge technology to deliver advanced dialysis therapy more easily — leaving more time for direct patient care. More patients can benefit from improved outcomes and a higher level of care quality. *6008 CAREsystem consists of the hemodialysis system 6008 and the

associated 6008

FRESENIUS MEDICAL CARE COMPANY HISTORY Fresenius Medical Care is the leading provider of dialysis products and services. Find out more about the company’s history.

CI-CA THERAPY

We would like to support you by offering a different dimension of CRRT treatment: Ci-Ca Therapy. Ci-Ca Therapy is a continuous renal replacement therapy method that was developed by Fresenius Medical Care. It was designed to provide reliable regional anticoagulation,

using

DIALYSIS WATER TECHNOLOGY Water technology solutions High quality water technology dialysis products and services tailored to your needs. Dialysis water supply Comprehensive water treatment systems for dialysis units. Concentrate supply Reliable preparation and supply of acid concentrate. Media supply Delivery of dialysis media to the point of care in a clean and IMAGES OF THERAPIES AND PRODUCTS 05/20/2021 Fresenius Medical Care: 2025 growth targets confirmed, Annual General Meeting approves 24th consecutive dividend increase ;

05/14/2021

EDUCATIONAL GRANTS

Qualifying organizations, as detailed above, may request an application form from Fresenius Medical Care at the following email address: edu-grants(at)fmc-ag.com. The application form for TPEs e.g. consists of 5 pages including mostly self-explanatory fields, of which some are completed automatically when other fields are filled in by

the requestor.

HEALTHCARE | RENAL | DIALYSIS Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.7 million patients worldwide regularly undergo dialysis treatment. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. STRATEGY - FRESENIUS MEDICAL CARE Our way forward – Strategy 2025. Creating a future worth living. For patients. Worldwide. Every day. This is our vision that unites all of us at Fresenius Medical Care – it always has and always will. We believe that in the future, health care will not be as we know it today. It faces multiple challenges: An ageing population and a rise

in

POLICIES AND STANDARDS Sustainability Accounting Standards Board (SASB) Index. Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

EMPLOYEES - FRESENIUS MEDICAL CARE We will continue to promote diversity in the future, emphasizing and embracing it as an asset. The average age of employees in 2019 was 41 years. Around 18 % of employees were below 30, the majority of. 56 % were between 30 and 50 years old and 26 % of employees were 50

6008 CARESYSTEM

With the 6008 CAREsystem*, Fresenius Medical Care leverages leading-edge technology to deliver advanced dialysis therapy more easily — leaving more time for direct patient care. More patients can benefit from improved outcomes and a higher level of care quality. *6008 CAREsystem consists of the hemodialysis system 6008 and the

associated 6008

FRESENIUS MEDICAL CARE COMPANY HISTORY Fresenius Medical Care is the leading provider of dialysis products and services. Find out more about the company’s history.

CI-CA THERAPY

We would like to support you by offering a different dimension of CRRT treatment: Ci-Ca Therapy. Ci-Ca Therapy is a continuous renal replacement therapy method that was developed by Fresenius Medical Care. It was designed to provide reliable regional anticoagulation,

using

DIALYSIS WATER TECHNOLOGY Water technology solutions High quality water technology dialysis products and services tailored to your needs. Dialysis water supply Comprehensive water treatment systems for dialysis units. Concentrate supply Reliable preparation and supply of acid concentrate. Media supply Delivery of dialysis media to the point of care in a clean and IMAGES OF THERAPIES AND PRODUCTS 05/20/2021 Fresenius Medical Care: 2025 growth targets confirmed, Annual General Meeting approves 24th consecutive dividend increase ;

05/14/2021

EDUCATIONAL GRANTS

Qualifying organizations, as detailed above, may request an application form from Fresenius Medical Care at the following email address: edu-grants(at)fmc-ag.com. The application form for TPEs e.g. consists of 5 pages including mostly self-explanatory fields, of which some are completed automatically when other fields are filled in by

the requestor.

NEWSROOM - FRESENIUS MEDICAL CARE Fresenius Medical Care to issue bonds with a volume of 1.5 billion US-dollars. Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has agreed to issue bonds with an aggregate principal amount of USD 1.5 billion across two tranches. 05/06/2021.

6008 CARESYSTEM

With the 6008 CAREsystem*, Fresenius Medical Care leverages leading-edge technology to deliver advanced dialysis therapy more easily — leaving more time for direct patient care. More patients can benefit from improved outcomes and a higher level of care quality. *6008 CAREsystem consists of the hemodialysis system 6008 and the

associated 6008

CORPORATE CULTURE

Corporate culture. "Creating a future worth living. For patients. Worldwide. Every day." This is our vision that unites all of us at Fresenius Medical Care. Our vision, mission and core values provide a clear framework and guidance for the behavior and actions of our diverse workforce all around the world. EMPLOYEES - FRESENIUS MEDICAL CARE We will continue to promote diversity in the future, emphasizing and embracing it as an asset. The average age of employees in 2019 was 41 years. Around 18 % of employees were below 30, the majority of. 56 % were between 30 and 50 years old and 26 % of employees were 50 CONTACT - FRESENIUS MEDICAL CARE USA. Tel: (001) 781 - 402 9000. Fax: (001) 781 - 402 9004. e-mail: corphr@fmc-na.com. Homepage: Career opportunities at Fresenius Medical

Care North America.

STRONGER TOGETHER THROUGHOUT THE PANDEMIC In Wuhan in China, from where the pandemic began its global spread, Fresenius Medical Care swiftly supplied local hospitals with donations of acute care devices and other materials to help maintain the healthcare infrastructure.We also delivered more than 100,000 face masks and other personal protection equipment to our employees in China. Qun Xiao was one of the first nurses to treat infected

PRODUCT INFORMATION

en English: Document library for product-related documents:Updates of product information (e.g. Instructions for Use, Manuals) are made available to the user via this website.The documents can be searched fast and easily by the product name or the article number in the

database.

CI-CA THERAPY

We would like to support you by offering a different dimension of CRRT treatment: Ci-Ca Therapy. Ci-Ca Therapy is a continuous renal replacement therapy method that was developed by Fresenius Medical Care. It was designed to provide reliable regional anticoagulation,

using

STAY-SAFE MYTRAINING VR The stay•safe MyTraining VR is an advanced digital training tool, that can support you in preparing your patients for their peritoneal dialysis therapy at home.. With virtual reality you can give your patients additional training opportunities, so they can repeat the steps of the bag exchange at their own pace as often as needed.. You support different learning styles with a mix of visual

ANNUAL REPORT

Our extensive expertise is the prerequisite for our long-term business success. We work for people who rely on dialysis to live. We are aware of this responsibility. That is why we exchange our ideas globally. We share our knowledge to continuously improve. For our patients. Living knowledge. Annual report. PDF, HEALTHCARE | RENAL | DIALYSIS Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.7 million patients worldwide regularly undergo dialysis treatment. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. STRATEGY - FRESENIUS MEDICAL CAREFRESENIUS MEDICAL CARE CALIFORNIAFRESENIUS FMCNAFRESENIUS MEDICAL CARE NORTH AMERICA Our way forward – Strategy 2025. Creating a future worth living. For patients. Worldwide. Every day. This is our vision that unites all of us at Fresenius Medical Care – it always has and always will. We believe that in the future, health care will not be as we know it today. It faces multiple challenges: An ageing population and a rise

in

ANNUAL GENERAL MEETING Annual General Meeting 2021. The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies. The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with STRONGER TOGETHER THROUGHOUT THE PANDEMIC The health and safety of our patients and our employees remains our top priority. This is also true in the face of the many challenges presented by the COVID-19 pandemic. As the leading provider of dialysis products and services, Fresenius Medical Care benefits from decades of experience, innovative technology and dedicated staff. POLICIES AND STANDARDS Sustainability Accounting Standards Board (SASB) Index. Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

DIALYSIS WATER TECHNOLOGY Water technology solutions High quality water technology dialysis products and services tailored to your needs. Dialysis water supply Comprehensive water treatment systems for dialysis units. Concentrate supply Reliable preparation and supply of acid concentrate. Media supply Delivery of dialysis media to the point of care in a clean and THERAPEUTIC APHERESIS OVERVIEW Extracorporeal blood purification procedures for removing pathogens, chemicals or cells from blood or plasma. Benefits a variety of medical conditions, including metabolic disorders and autoimmune diseases. Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. BASE PROSPECTUS MAY 19, 2020 2 RESPONSIBILITY STATEMENT Fresenius Medical Care AG & Co. KGaA (the Issuer and, together with its consolidated group companies, the Group, also referred to as we, us or our), with its registered seat (Sitz) in Hof an der Saale, Germany, and its registered of- fice in Bad Homburg vor der Höhe, Germany, and the Guarantor accept responsibility for the information given in OUR CODE OF ETHICS AND BUSINESS CONDUCT The guidelines of our Code of Ethics and Business Conduct are mandatory for all the Company’s employees and managers, including members of the Management Board. The Code also applies to the operations of all direct and indirect subsidiaries that are majority-owned or controlled by us in some other way. Considerable training and intensified FRESENIUS MEDICAL CARE EXPANDS TCU NETWORK IN THE USAFRESENIUS CRRT MACHINEFRESENIUS CRRT MACHINEFRESENIUS CRRT MANUALFRESENIUS CRRT MANUALFRESENIUS DIALYSIS LOCATIONS Fresenius Medical Care North America intends to open more than 100 new transitional care units (TCUs) this year. These units will help people recently diagnosed with kidney failure learn about the treatment options available to them including home dialysis, and become more HEALTHCARE | RENAL | DIALYSIS Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.7 million patients worldwide regularly undergo dialysis treatment. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. STRATEGY - FRESENIUS MEDICAL CAREFRESENIUS MEDICAL CARE CALIFORNIAFRESENIUS FMCNAFRESENIUS MEDICAL CARE NORTH AMERICA Our way forward – Strategy 2025. Creating a future worth living. For patients. Worldwide. Every day. This is our vision that unites all of us at Fresenius Medical Care – it always has and always will. We believe that in the future, health care will not be as we know it today. It faces multiple challenges: An ageing population and a rise

in

ANNUAL GENERAL MEETING Annual General Meeting 2021. The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies. The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with STRONGER TOGETHER THROUGHOUT THE PANDEMIC The health and safety of our patients and our employees remains our top priority. This is also true in the face of the many challenges presented by the COVID-19 pandemic. As the leading provider of dialysis products and services, Fresenius Medical Care benefits from decades of experience, innovative technology and dedicated staff. POLICIES AND STANDARDS Sustainability Accounting Standards Board (SASB) Index. Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

DIALYSIS WATER TECHNOLOGY Water technology solutions High quality water technology dialysis products and services tailored to your needs. Dialysis water supply Comprehensive water treatment systems for dialysis units. Concentrate supply Reliable preparation and supply of acid concentrate. Media supply Delivery of dialysis media to the point of care in a clean and THERAPEUTIC APHERESIS OVERVIEW Extracorporeal blood purification procedures for removing pathogens, chemicals or cells from blood or plasma. Benefits a variety of medical conditions, including metabolic disorders and autoimmune diseases. Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. BASE PROSPECTUS MAY 19, 2020 2 RESPONSIBILITY STATEMENT Fresenius Medical Care AG & Co. KGaA (the Issuer and, together with its consolidated group companies, the Group, also referred to as we, us or our), with its registered seat (Sitz) in Hof an der Saale, Germany, and its registered of- fice in Bad Homburg vor der Höhe, Germany, and the Guarantor accept responsibility for the information given in OUR CODE OF ETHICS AND BUSINESS CONDUCT The guidelines of our Code of Ethics and Business Conduct are mandatory for all the Company’s employees and managers, including members of the Management Board. The Code also applies to the operations of all direct and indirect subsidiaries that are majority-owned or controlled by us in some other way. Considerable training and intensified FRESENIUS MEDICAL CARE EXPANDS TCU NETWORK IN THE USAFRESENIUS CRRT MACHINEFRESENIUS CRRT MACHINEFRESENIUS CRRT MANUALFRESENIUS CRRT MANUALFRESENIUS DIALYSIS LOCATIONS Fresenius Medical Care North America intends to open more than 100 new transitional care units (TCUs) this year. These units will help people recently diagnosed with kidney failure learn about the treatment options available to them including home dialysis, and become more FRESENIUS MEDICAL CARE INVESTOR RELATIONS Fresenius Medical Care to issue bonds with a volume of 1.5 billion US-dollars. Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has agreed to issue bonds with an aggregate principal amount of USD NEWSROOM - FRESENIUS MEDICAL CARE Fresenius Medical Care to issue bonds with a volume of 1.5 billion US-dollars. Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has agreed to issue bonds with an aggregate principal amount of USD 1.5 billion across two tranches. 05/06/2021.

PRODUCT INFORMATION

en English: Document library for product-related documents:Updates of product information (e.g. Instructions for Use, Manuals) are made available to the user via this website.The documents can be searched fast and easily by the product name or the article number in the

database.

EMPLOYEES - FRESENIUS MEDICAL CARE We will continue to promote diversity in the future, emphasizing and embracing it as an asset. The average age of employees in 2019 was 41 years. Around 18 % of employees were below 30, the majority of. 56 % were between 30 and 50 years old and 26 % of employees were 50 STRONGER TOGETHER THROUGHOUT THE PANDEMIC In Wuhan in China, from where the pandemic began its global spread, Fresenius Medical Care swiftly supplied local hospitals with donations of acute care devices and other materials to help maintain the healthcare infrastructure.We also delivered more than 100,000 face masks and other personal protection equipment to our employees in China. Qun Xiao was one of the first nurses to treat infected STAY-SAFE MYTRAINING VR The stay•safe MyTraining VR is an advanced digital training tool, that can support you in preparing your patients for their peritoneal dialysis therapy at home.. With virtual reality you can give your patients additional training opportunities, so they can repeat the steps of the bag exchange at their own pace as often as needed.. You support different learning styles with a mix of visual HEMODIALYSIS OVERVIEW Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. Fresenius Medical Care supports nephrologists worldwide

in minimizing

SUSTAINABILITY OVERVIEW Our patients are at the heart of everything we do. This also determines the way we look at sustainability. Our commitment to sustainability is incorporated in our vision and our mission.It is also reflected in our strategy to deliver sustainable solutions with innovative products and services of the highest quality at a reliable cost. Managing sustainability successfully means creating lasting THERAPEUTIC APHERESIS OVERVIEW Extracorporeal blood purification procedures for removing pathogens, chemicals or cells from blood or plasma. Benefits a variety of medical conditions, including metabolic disorders and autoimmune diseases. Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. FRESENIUS MEDICAL CARE COMPLETES ACQUISITION OF NXSTAGE 1 The total integration costs are lower than previously communicated mainly due to costs that will be considered pre-merger expenses of NxStage, certain other costs that qualify for purchase accounting or as capital expenditures and previously recognized transaction and legal costs. 2 The numbers are excluding effects from the implementation of IFRS 16 and excluding integration costs. 2019 HEALTHCARE | RENAL | DIALYSIS WHO WE ARE. Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which

around 3.7 million

STRATEGY - FRESENIUS MEDICAL CAREFRESENIUS MEDICAL CARE CALIFORNIAFRESENIUS FMCNAFRESENIUS MEDICAL CARE NORTH AMERICA Fresenius Medical Care aims to further consolidate its expertise as the world's largest provider of top-quality dialysis treatments and products and to apply them as a basis for sustainable, profitable

growth.

NEWSROOM - FRESENIUS MEDICAL CAREFRESENIUS KIDNEY CARE JOBSFRESENIUS KIDNEY CARE LOCATIONSFRESENIUS KIDNEY CARE UNIFORMS Throughout 2020, Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, reported COVID-19 affecting patients with advanced kidney disease and, in particular, the severity of illness resulting in an increased

mortality.

ANNUAL GENERAL MEETING The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies. POLICIES AND STANDARDS Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

DIALYSIS WATER TECHNOLOGY Dialysis water technology solutions for healthcare professionals. Attention . The medical device and therapy related information on this website is aimed exclusively at healthcare professionals located within the European Union. BASE PROSPECTUS MAY 19, 2020 2 RESPONSIBILITY STATEMENT Fresenius Medical Care AG & Co. KGaA (the Issuer and, together with its consolidated group companies, the Group, also referred to as we, us or our), with its registered seat (Sitz) in Hof an der Saale, Germany, and its registered of- fice in Bad Homburg vor der Höhe, Germany, and the Guarantor accept responsibility for the information given in THERAPEUTIC APHERESIS OVERVIEW Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. This can lead to a medical

improvement when

OUR CODE OF ETHICS AND BUSINESS CONDUCT Our global compliance program comprises the Code of Ethics and Business Conduct which covers topics that are relevant for our business - from patient care, quality, anti-corruption and bribery to health and safety, data privacy or environmental protection. FRESENIUS MEDICAL CARE EXPANDS TCU NETWORK IN THE USAFRESENIUS CRRT MACHINEFRESENIUS CRRT MACHINEFRESENIUS CRRT MANUALFRESENIUS CRRT MANUALFRESENIUS DIALYSIS LOCATIONS Fresenius Medical Care North America intends to open more than 100 new transitional care units (TCUs) this year. These units will help people recently diagnosed with kidney failure learn about the treatment options available to them including home dialysis, and become more HEALTHCARE | RENAL | DIALYSIS WHO WE ARE. Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which

around 3.7 million

STRATEGY - FRESENIUS MEDICAL CAREFRESENIUS MEDICAL CARE CALIFORNIAFRESENIUS FMCNAFRESENIUS MEDICAL CARE NORTH AMERICA Fresenius Medical Care aims to further consolidate its expertise as the world's largest provider of top-quality dialysis treatments and products and to apply them as a basis for sustainable, profitable

growth.

NEWSROOM - FRESENIUS MEDICAL CAREFRESENIUS KIDNEY CARE JOBSFRESENIUS KIDNEY CARE LOCATIONSFRESENIUS KIDNEY CARE UNIFORMS Throughout 2020, Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, reported COVID-19 affecting patients with advanced kidney disease and, in particular, the severity of illness resulting in an increased

mortality.

ANNUAL GENERAL MEETING The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies. POLICIES AND STANDARDS Our Sustainability Accounting Standards Board (SASB) Index discloses information in alignment with SASB’s Health Care Delivery Standard. This is part of our commitment to provide transparent and relevant information on our economical, environmental and social performance to

our stakeholders.

DIALYSIS WATER TECHNOLOGY Dialysis water technology solutions for healthcare professionals. Attention . The medical device and therapy related information on this website is aimed exclusively at healthcare professionals located within the European Union. BASE PROSPECTUS MAY 19, 2020 2 RESPONSIBILITY STATEMENT Fresenius Medical Care AG & Co. KGaA (the Issuer and, together with its consolidated group companies, the Group, also referred to as we, us or our), with its registered seat (Sitz) in Hof an der Saale, Germany, and its registered of- fice in Bad Homburg vor der Höhe, Germany, and the Guarantor accept responsibility for the information given in THERAPEUTIC APHERESIS OVERVIEW Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. This can lead to a medical

improvement when

OUR CODE OF ETHICS AND BUSINESS CONDUCT Our global compliance program comprises the Code of Ethics and Business Conduct which covers topics that are relevant for our business - from patient care, quality, anti-corruption and bribery to health and safety, data privacy or environmental protection. FRESENIUS MEDICAL CARE EXPANDS TCU NETWORK IN THE USAFRESENIUS CRRT MACHINEFRESENIUS CRRT MACHINEFRESENIUS CRRT MANUALFRESENIUS CRRT MANUALFRESENIUS DIALYSIS LOCATIONS Fresenius Medical Care North America intends to open more than 100 new transitional care units (TCUs) this year. These units will help people recently diagnosed with kidney failure learn about the treatment options available to them including home dialysis, and become more FRESENIUS MEDICAL CARE INVESTOR RELATIONS Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has agreed to issue bonds with an aggregate principal amount of

PRODUCT INFORMATION

en English: Document library for product-related documents:Updates of product information (e.g. Instructions for Use, Manuals) are made available to the user via this website.The documents can be searched fast and easily by the product name or the article number in the

database.

STAY-SAFE MYTRAINING VR The stay•safe MyTraining VR is an advanced digital training tool, that can support you in preparing your patients for their peritoneal dialysis therapy at home.. With virtual reality you can give your patients additional training opportunities, so they can repeat the steps of the bag exchange at their own pace as often as needed.. You support different learning styles with a mix of visual EMPLOYEES - FRESENIUS MEDICAL CARE Fresenius Medical Care brings together a wide range of cultures and skills under one roof. We value the diversity that our employees provide in the form of their qualifications, personal strengths, characteristics, interests, perspectives and ideas. STRONGER TOGETHER THROUGHOUT THE PANDEMIC In Wuhan in China, from where the pandemic began its global spread, Fresenius Medical Care swiftly supplied local hospitals with donations of acute care devices and other materials to help maintain the healthcare infrastructure.We also delivered more than 100,000 face masks and other personal protection equipment to our employees in China. Qun Xiao was one of the first nurses to treat infected HEMODIALYSIS OVERVIEW Minimizing your patients’ risks for cardiovascular morbidity and mortality. Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis

patients.

FINANCIAL REPORTING

05/20/2021 Fresenius Medical Care: 2025 growth targets confirmed, Annual General Meeting approves 24th consecutive dividend increase ;

05/14/2021

DIALYSIS WATER TECHNOLOGY Dialysis water technology solutions for healthcare professionals. Attention . The medical device and therapy related information on this website is aimed exclusively at healthcare professionals located within the European Union. FRESENIUS MEDICAL CARE COMPLETES ACQUISITION OF NXSTAGE 1 The total integration costs are lower than previously communicated mainly due to costs that will be considered pre-merger expenses of NxStage, certain other costs that qualify for purchase accounting or as capital expenditures and previously recognized transaction and legal costs. 2 The numbers are excluding effects from the implementation of IFRS 16 and excluding integration costs. 2019 THERAPEUTIC APHERESIS OVERVIEW Therapeutic apheresis is a therapy for removing pathogenic substances from blood using filters and adsorbers. This can lead to a medical

improvement when

Search

Fresenius Medical Care uses cookies on this website to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. For details see our privacy policy.

OK

* English

* |

* Deutsch

* Patients & Families * Patients & Families overview

* Kidney disease

* Understanding dialysis

* Treatment options

* Living with chronic kidney disease * Family & caregivers * Services from Fresenius Medical Care * Dialysis center finder

* Glossary

* Healthcare Professionals * Healthcare Professionals overview

* Hemodialysis

* Hemodialysis overview

* HighVolumeHDF

* Machines

* Machines overview

* 6008 CAREsystem

* 5008 CorDiax & 5008S CorDiax

* 4008S classix

* Dialyzers

* Dialyzers overview

* Water technology

* Water technology overview * Water technology solutions * Dialysis water supply * Concentrate supply

* Media supply

* Home therapies

* Home therapies overview

* Adapted APD

* APD

* APD overview

* sleep•safe

* sleep•safe harmony * stay•safe and Biofine

* Volume control

* Home hemodialysis

* Pediatric dialysis * Pediatric dialysis overview * Pediatric peritoneal dialysis * Pediatric hemodialysis

* Acute therapies

* Acute therapies overview

* CRRT setups

* Ci-Ca multiIntenseCare

* multiFiltratePRO

* multiFiltrate

* CRRT and plasmapheresis filters

* Vascular access

* Therapeutic apheresis * Therapeutic apheresis overview

* Renal IT

* Renal IT overview

* Therapy Data Management System (TDMS) * Therapy Monitor (TMon) * Therapy Support Suite (TSS) * communication Data Link (cDL) * Nephrologic Cockpit * PatientOnLine (POL) * Clinical management * Service and support

* Physicians

* Nurses

* Services and resources * Services and resources overview * Training and education * Events and congresses

* Ventures

* Educational grants

* Investors

* Investors overview

* At a glance

* Overview at a glance

* Facts & figures

* Outlook

* Shares

* Overview shares

* Share price

* Share data

* Dividend

* Investment calculator

* Share buy-back

* ADR program

* NxStage

* Shareholder structure * Analysts' estimates

* Operating figures

* News & publications * Overview news & publications

* AD Hoc News

* Financial reports

* Annual reports

* Events & Presentations * Overview Events & Presentations * Financial Reporting * Conferences and Roadshows * Meet the Management * Acquisition_NxStage * Annual General Meeting

* Credit Relations

* Corporate Governance * Overview Corporate Governance * Declaration of Compliance * Statement on gender equality

* Legal structure

* Directors' Dealings * Declaration on Corporate Governance * Investor Relations contacts

* Media

* Media overview

* News

* Stories

* Videos

* Events

* Images

* Publications

* Blue art project

* About us

* About us overview

* Company profile

* Corporate culture

* Strategy

* Responsibility

* Compliance

* Management Board

* Supervisory Board

* History

* Contact

* Career

Country websites:

Global websiteArgentinaAsia PacificAustraliaAustriaBrazilBulgariaChileChinaColombiaCzech RepublicDenmarkEcuadorFinlandFranceGermanyHungaryIndonesiaItalyJapanKazakhstanMalaysiaMexicoMiddle EastNetherlandsPolandPortugalRomaniaRussiaSingaporeSouth KoreaSwedenTurkeyUnited KingdomUnited StatesVietnam

Patients & families

Healthcare professionals

Investors

Media

About us

Search

CARE AND LIVE - OUR MAGAZINE 2018 CARE AND LIVE - OUR MAGAZINE 2018

Learn more

A MARKET IN MOTION — DIALYSIS CARE IN CHINA A MARKET IN MOTION — DIALYSIS CARE IN CHINA

Learn more

*

*

WHEN MARIA STRUCK — ONE YEAR AFTER THE HURRICANE WHEN MARIA STRUCK — ONE YEAR AFTER THE HURRICANE

Read more

*

*

*

*

CARE AND LIVE - OUR MAGAZINE 2018 CARE AND LIVE - OUR MAGAZINE 2018

Learn more

A MARKET IN MOTION — DIALYSIS CARE IN CHINA A MARKET IN MOTION — DIALYSIS CARE IN CHINA

Learn more

*

*

WHEN MARIA STRUCK — ONE YEAR AFTER THE HURRICANE WHEN MARIA STRUCK — ONE YEAR AFTER THE HURRICANE

Read more

*

*

*

*

CARE AND LIVE - OUR MAGAZINE 2018 CARE AND LIVE - OUR MAGAZINE 2018

Learn more

* 1

* 2

* 3

News

07/30/2019

Press release

Fresenius Medical Care on track to achieve full-year targets after solid second quarter

07/19/2019

Press release

Fresenius Medical Care celebrates 40th anniversary of Schweinfurt plant, company’s largest for dialysis machines

07/10/2019

Press release

Fresenius Medical Care sees U.S. plans for changes to kidney disease care as positive reinforcement of company’s strategy

07/03/2019

Press release

Fresenius Medical Care expands clinical research activities

JULY 30, 2019

Q2 2019 EARNINGS RELEASE

Learn more

MEDIA

MEDIA CENTER

Learn more

PUBLICATIONS

CARE AND LIVE

Our Annual Report 2018

Learn More

HOME HEMODIALYSIS

NXSTAGE JOINS THE FRESENIUS MEDICAL CARE FAMILY

Learn more

HEALTHCARE PROFESSIONALS PRODUCTS, THERAPIES AND SERVICES FOR HEALTHCARE PROFESSIONALS

Learn more

PATIENTS & FAMILIES

PATIENTS & FAMILIES

Learn more

Stories

*

One year after the hurricane

*

Cradle of innovation

*

The history of dialysis

*

Integrating Peritoneal Dialysis (PD) therapy into an active and mobile

life

*

Prevention programs can slow down the progression of kidney disease

*

An almost normal life thanks to home dialysis

*

The East-West connection story

*

Learning to move

*

17,962 miles halfway around the world

*

A vast island nation

*

The future is purple

*

20 years creating a future worth living

*

Africa changing times

*

Diary of a dialysis patient

*

A successful series-produced model

* Previous

* Next

WHO WE ARE

Fresenius Medical Care is the world’s leading provider of dialysis products and services. We care for people with chronic kidney failure, of whom around 3.4 million worldwide depend on dialysis treatment. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life.

*

119,631

employees

*

50 M

Treatments

*

339,550

patients served

*

3,996

clinics

Find your clinic

*

42

Production sites

*

119,631

employees

*

50 M

Treatments

* 1

* 2

* 3

* 4

* 5

* Previous

* Next

Patients & families

Healthcare professionals

Investors

Media

About us

NEWS

*

07/30/2019

Fresenius Medical Care on track to achieve full-year targets after solid second quarter

*

07/19/2019

Fresenius Medical Care celebrates 40th anniversary of Schweinfurt plant, company’s largest for dialysis machines

*

07/10/2019

Fresenius Medical Care sees U.S. plans for changes to kidney disease care as positive reinforcement of company’s strategy

See all news

MEDIA CENTER

*

VIDEO

20 years creating a future worth living video

*

STORY

The future is purple

*

STORY

The history of dialysis

Go to Media center

QUICK LINKS

INVESTORS

Events & presentations HEALTHCARE PROFESSIONALS Training and education

Events & congresses

Educational grants

LEGAL AND REGULATORY SVCH information (REACH)

Trade governance

CONTACT

COUNTRY WEBSITES

Global websiteArgentinaAsia PacificAustraliaAustriaBrazilBulgariaChileChinaColombiaCzech RepublicDenmarkEcuadorFinlandFranceGermanyHungaryIndonesiaItalyJapanKazakhstanMalaysiaMexicoMiddle EastNetherlandsPolandPortugalRomaniaRussiaSingaporeSouth KoreaSwedenTurkeyUnited KingdomUnited StatesVietnamAll contact

information

FIND US ON

*

*

*

*

* Privacy policy

* Cookie declaration

* Imprint

* Sitemap

� Fresenius Medical Care AG & Co. KGaA 2019